You are here

• Home
• Therapy Areas
• Neuroscience

• A Phase I, single centre, randomised, double-blind, placebo-controlled study to assess the safety, tolerability and pharmacokinetics of a single dose and multiple doses of TC-5214 (S-Mecamylamine) in healthy male Japanese subjects

Disease

depression

Drug Name

TC-5214

Generic Name

TC-5214

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

Jul 20, 2010

Study Name

D4131C00002

Study Id

D4131C00002

ClinicalTrials.gov ID

NCT01175564

Recruiting Status

Closed

Protocol Status

Not Available

Report

Jan 12, 2011

• D4131C00002.pdf (118 KB)

Page tools

• Print
• Bookmark this page